Nishio K - Search Results

1

Differential gene expression profile between PC-14 cells treated with free cisplatin and cisplatin-incorporated polymeric micelles.

Nishiyama N, Koizumi F, Okazaki S, Matsumura Y, Nishio K, Kataoka K. Nishiyama N, et al. Among authors: nishio k. Bioconjug Chem. 2003 Mar-Apr;14(2):449-57. doi: 10.1021/bc025555t. Bioconjug Chem. 2003. PMID: 12643756

2

In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice.

Heike Y, Takahashi M, Ohira T, Arioka H, Funayama Y, Nishio K, Ogasawara H, Saijo N. Heike Y, et al. Among authors: nishio k. Cancer Chemother Pharmacol. 1995;35(3):200-4. doi: 10.1007/BF00686548. Cancer Chemother Pharmacol. 1995. PMID: 7805177

3

Molecular determinants of UCN-01-induced growth inhibition in human lung cancer cells.

Usuda J, Saijo N, Fukuoka K, Fukumoto H, Kuh HJ, Nakamura T, Koh Y, Suzuki T, Koizumi F, Tamura T, Kato H, Nishio K. Usuda J, et al. Among authors: nishio k. Int J Cancer. 2000 Jan 15;85(2):275-80. doi: 10.1002/(sici)1097-0215(20000115)85:2<275::aid-ijc20>3.0.co;2-5. Int J Cancer. 2000. PMID: 10629089

4

In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction.

Kanzawa F, Koizumi F, Koh Y, Nakamura T, Tatsumi Y, Fukumoto H, Saijo N, Yoshioka T, Nishio K. Kanzawa F, et al. Among authors: nishio k. Clin Cancer Res. 2001 Jan;7(1):202-9. Clin Cancer Res. 2001. PMID: 11205910

5

Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.

Nakamura T, Koizumi F, Kaneko N, Tamura T, Chiwaki F, Koh Y, Akutagawa S, Saijo N, Nishio K. Nakamura T, et al. Among authors: nishio k. Jpn J Cancer Res. 2001 Jun;92(6):597-602. doi: 10.1111/j.1349-7006.2001.tb01136.x. Jpn J Cancer Res. 2001. PMID: 11429046 Free PMC article.

6

Differential osteopontin expression in lung cancer.

Zhang J, Takahashi K, Takahashi F, Shimizu K, Ohshita F, Kameda Y, Maeda K, Nishio K, Fukuchi Y. Zhang J, et al. Among authors: nishio k. Cancer Lett. 2001 Oct 10;171(2):215-22. doi: 10.1016/s0304-3835(01)00607-3. Cancer Lett. 2001. PMID: 11520606

7

Gene expression profiling of exposure to TZT-1027, a novel microtubule-interfering agent, in non-small cell lung cancer PC-14 cells and astrocytes.

Natsume T, Nakamura T, Koh Y, Kobayashi M, Saijo N, Nishio K. Natsume T, et al. Among authors: nishio k. Invest New Drugs. 2001;19(4):293-302. doi: 10.1023/a:1010605625538. Invest New Drugs. 2001. PMID: 11561688

8

Enhanced anti-tumor effect of trastuzumab in combination with cisplatin.

Naruse I, Fukumoto H, Saijo N, Nishio K. Naruse I, et al. Among authors: nishio k. Jpn J Cancer Res. 2002 May;93(5):574-81. doi: 10.1111/j.1349-7006.2002.tb01293.x. Jpn J Cancer Res. 2002. PMID: 12036454 Free PMC article.

9

Up-regulated gene expression of angiogenesis factors in post-chemotherapeutic lung cancer tissues determined by cDNA macroarray.

Ohira T, Akutagawa S, Usuda J, Nakamura T, Hirano T, Tsuboi M, Nishio K, Taguchi F, Ikeda N, Nakamura H, Konaka C, Saijo N, Kato H. Ohira T, et al. Among authors: nishio k. Oncol Rep. 2002 Jul-Aug;9(4):723-8. Oncol Rep. 2002. PMID: 12066199

10

Non-cross resistance of ZD0473 in acquired cisplatin-resistant lung cancer cell lines.

Kawamura-Akiyama Y, Kusaba H, Kanzawa F, Tamura T, Saijo N, Nishio K. Kawamura-Akiyama Y, et al. Among authors: nishio k. Lung Cancer. 2002 Oct;38(1):43-50. doi: 10.1016/s0169-5002(02)00175-7. Lung Cancer. 2002. PMID: 12367792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,208 results

Search Page

Filters